Pharmacoeconomic considerations in anaesthetic use.
Healthcare costs are rising in all areas of medicine, especially in high technology specialities such as anaesthesia. Therefore, cost containment and reduction have become major goals in many hospitals and anaesthesia departments. One area that has received substantial attention is the cost of pharmaceutical products, in particular the cost of newer, shorter-acting inhaled and intravenous anaesthetics, analgesics and neuromuscular blocking agents. Numerous pharmacoeconomic studies have been published on the theoretical analysis of anaesthetic drug costs and the potential benefit of various anaesthesia techniques. However, the results are not conclusive and anaesthesia departments continue to seek ways to reduce costs. In this review, we intend to discuss cost terminology, common areas of cost containment in anaesthesia and the relationship of anaesthesia care costs to total perioperative costs.
Department of Anaesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstr. 79, Germany. suttner@gmx.de
Stefan
S
Suttner
Bernhard
B
Kumle
Joachim
J
Boldt
D000769:Anesthesia, Inhalation / Q000191:economics; D000771:Anesthesia, Intravenous / Q000191:economics; D000777:Anesthetics / Q000191:economics* / Q000627:therapeutic use*; D003365:Costs and Cost Analysis / Q000379:methods / Q000706:statistics & numerical data; D017850:Economics, Pharmaceutical / Q000706:statistics & numerical data; D006801:Humans
D000777:Anesthetics